Brainstorm Cell Therapeutics Inc.
(NASDAQ : BCLI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading BCLI News...
...
Electronic Technology » Computer Peripherals
symbolcompany%chnglast%shortavg$volume
WDCWestern Digital Corporation
3.42%93.342.3%$376.80m
STXSeagate Technology PLC
1.57%42.678.8%$158.43m
NTAPNetApp, Inc.
1.94%39.872.9%$134.37m
SYNASynaptics Incorporated
0.74%59.9918.5%$68.88m
ZBRAZebra Technologies Corporation Class A
0.16%105.254.2%$41.76m
PSTGPure Storage, Inc. Class A
0.30%13.347.7%$37.95m
EFIIElectronics For Imaging, Inc.
-0.94%48.4713.0%$16.93m
LOGILogitech International S.A.
0.35%37.064.9%$16.25m
QTMQuantum Corporation
-1.66%6.840.6%$2.88m
AVIDAvid Technology, Inc.
-1.75%5.0512.1%$2.04m
IMMRImmersion Corporation
0.69%8.805.4%$1.31m
DRAMDataram Corporation
-0.33%3.036.1%$1.08m
BCLIBrainstorm Cell Therapeutics Inc.
1.16%4.375.3%$0.39m
QBAKQualstar Corporation
2.34%5.240.8%$0.23m
ALOTAstro-Med, Inc.
0.38%13.350.6%$0.15m

Company Profile

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in Hackensack, NJ.,0038F6-E